Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
04/2013
04/03/2013CN102391259B Nifuratel compound and preparation method thereof
04/03/2013CN101553471B 抗菌喹啉衍生物 Antibacterial quinoline derivatives
04/02/2013US8410282 Compounds as adenosine A1 receptor antagonists
04/02/2013US8410277 Method for manufacturing heterocycle substituted pyridine derivatives
04/02/2013US8410272 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
04/02/2013US8410266 2,4-pyrimidinediamine compounds and their uses
04/02/2013US8410160 5-membered heterocycle-based P38 kinase inhibitors
04/02/2013US8410159 Imidazole compounds having pharmaceutical activity towards the sigma receptor
04/02/2013US8410110 9-(piperazinylalkyl) carbazoles as Bax-modulators
04/02/2013US8410104 Pyridazines
04/02/2013US8410095 Thiazolopyrimidinone derivatives as PI3 kinase inhibitors
04/02/2013US8410093 Cycloalkyl substituted pyrimidinediamine compounds and their uses
04/02/2013US8410088 Aryl- or heteroaryl-substituted benzene compounds
04/02/2013US8410023 Compositions and methods for controlling nematodes
04/02/2013CA2715143C Novel phenylpyrrole derivative
04/02/2013CA2595544C Compounds having analgesic and/or immunostimulant activity
04/02/2013CA2585642C Carbazole derivatives, solvates thereof, or pharmaceutically acceptable salts thereof
04/02/2013CA2564085C Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
04/02/2013CA2550843C Novel phenylalanine derivatives
04/02/2013CA2475633C Heteroaryl compounds useful as inhibitors of gsk-3
03/2013
03/28/2013WO2013043232A2 8-ethyl-6-(aryl)pyrido [2,3-d]pyrimidin-7(8h) -ones for the treatment of nervous system disorders and cancer
03/28/2013WO2013043192A1 Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders
03/28/2013WO2013042139A1 Amide compounds, compositions and applications thereof
03/28/2013WO2013042137A1 Bicyclic heterocycles as irak4 inhibitors
03/28/2013WO2013042135A1 Heteroaryl compounds as 5-ht4 receptor ligands
03/28/2013WO2013042067A1 Process for the preparation of potassium salt of azilsartan medoxomil
03/28/2013WO2013042066A1 Process for the preparation of azilsartan medoxomil
03/28/2013WO2013041652A1 Morpholino substituted urea or carbamate derivatives as mtor inhibitors
03/28/2013WO2013041651A1 Novel crystalline forms of rivaroxaban and processes for their preparation
03/28/2013WO2013041602A1 Use of 4-substituted 1-phenyl-pyrazole-3-carboxylic-acid derivatives as agents against abiotic plant stress
03/28/2013WO2013041499A1 N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e][1,3]oxazin-4-yl)-phenyl)-amides as bace1 inhibitors
03/28/2013WO2013041457A1 N-piperidin-4-yl derivatives
03/28/2013WO2013041042A1 Pyrazole carboxamides as janus kinase inhibitors
03/28/2013WO2013040790A1 Substituted pyrimidines
03/28/2013WO2013040789A1 Substituted pyrimidines
03/28/2013WO2013016720A3 Novel substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases
03/28/2013WO2012166463A3 Aminooxazole inhibitors of cyclin dependent kinases
03/28/2013WO2012155066A3 Spiro-oxindole mdm2 antagonists
03/28/2013WO2011006935A3 Tetrazole derivatives
03/28/2013US20130079513 N-Thio-anthranilamid compounds and their use as pesticides
03/28/2013US20130079374 Tricyclic compound and pharmaceutical use thereof
03/28/2013US20130079362 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
03/28/2013US20130079360 Raltegravir salts and crystalline forms thereof
03/28/2013US20130079347 Novel sulfonylpyrroles
03/28/2013US20130079345 Pharmaceutically active disubstituted triazine derivatives
03/28/2013US20130079343 1,3,6-Substituted Indole Derivatives Having Inhibitory Activity for Protein Kinase
03/28/2013US20130079342 Heterocyclic compounds and their uses
03/28/2013US20130079340 Benzothiazoles Having Histamine H3 Receptor Activity
03/28/2013US20130079339 Trpv1 vanilloid receptor antagonists with a bicyclic portion
03/28/2013US20130079338 Selective NR2B Antagonists
03/28/2013US20130079329 INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/Beta-CATENIN SIGNALING PATHWAY INHIBITORS
03/28/2013US20130079326 N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
03/28/2013US20130079325 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
03/28/2013US20130079320 Amine Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands
03/28/2013US20130079313 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
03/28/2013US20130079303 Inhibitors of PI3 Kinase and/or mTOR
03/28/2013US20130079271 Reversed biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
03/28/2013US20130078215 Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions
03/28/2013CA2849726A1 Amide compounds, compositions and applications thereof
03/28/2013CA2849189A1 Morpholino substituted urea or carbamate derivatives as mtor inhibitors
03/28/2013CA2849169A1 Pyrazole carboxamides as janus kinase inhibitors
03/28/2013CA2849109A1 N-piperidin-4-yl derivatives
03/28/2013CA2844654A1 N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e][1,3]oxazin-4-yl)-phenyl)-amides as bace1 inhibitors
03/28/2013CA2832309A1 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of nervous system disorders and cancer
03/28/2013CA2823548A1 Heteroaryl compounds as 5-ht4 receptor ligands
03/27/2013EP2573084A1 Novel crystalline forms of rivaroxaban and processes for their preparation
03/27/2013EP2573079A2 Benzimidazole quinolinones and uses thereof
03/27/2013EP2571884A2 Mtor selective kinase inhibitors
03/27/2013EP2571872A1 Compounds
03/27/2013EP2571866A1 Fungicidal oximes and hydrazones
03/27/2013EP2571359A1 Novel prolylcarboxypeptidase inhibitors
03/27/2013CN1972916B 肉桂酰胺类化合物 Cinnamic amides
03/27/2013CN1964956B Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
03/27/2013CN103003271A Novel rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of AIDS containing the rhodanine derivatives as active ingredients
03/27/2013CN103003269A Substituted heterocyclyl benzyl pyrazoles, and use thereof
03/27/2013CN103003268A Isoxazole, isothiazole, furane and thiophene compounds as microbicides
03/27/2013CN103003267A Sigma receptor inhibitors
03/27/2013CN103003266A Hydroxyalkyl benzyl pyrazoles, and use thereof for the treatment of hyperproliferative and angiogenic diseases
03/27/2013CN103003265A Microbicides
03/27/2013CN103003263A Novel hetaryl (thio)carboxamide compounds for controlling invertebrate pests
03/27/2013CN103003262A Nitrogenated aromatic heterocyclic ring derivative
03/27/2013CN103003243A Complex compound and optical recording medium containing same
03/27/2013CN102994073A Benzoxazole-based fluorescent-identified RAFT reagent, synthesis method and application
03/27/2013CN102993193A Use of nitrogen-3-isoxazolyl-3-4-thienyl-pyrimidyl sulfonyl propanamide derivative in preparing anti-tumor medicines
03/27/2013CN102993192A Oxazolidinone compound as well as preparation method and application thereof
03/27/2013CN102993191A Heterocyclic chiral compound containing azlactone and pyrazolone, and derivative, synthetic method and use thereof
03/27/2013CN102993189A Hydrazone-containing triazolinone compounds and uses thereof
03/27/2013CN102993084A Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/27/2013CN102988362A Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
03/27/2013CN102267971B Alicyclic-o[c] benzopyrone derivative and application thereof
03/27/2013CN102036955B Hydroxamate-based inhibitors of deacetylases b
03/27/2013CN102026989B Medicinal composition containing benzo[a]phenoxanthin compound as the active ingredient for preventing or treating protozoal disease
03/27/2013CN101903340B Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
03/27/2013CN101679287B Nicotinic acetylcholine receptor modulators
03/27/2013CN101627028B Substituted diazepan compounds as orexin receptor antagonists
03/27/2013CN101616902B 2-aminooxazolines as TAAR1 ligands
03/27/2013CN101558040B Dihydropyridine derivatives useful as protein kinase inhibitors
03/27/2013CN101528716B Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
03/27/2013CN101460482B Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity
03/27/2013CN101448785B Novel dipeptidyl peptidase iv inhibitors and processes for preparation and pharmaceutical compositions thereof containing the same
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 647